InvestorBrandNetwork (IBN) Content Platform

Cub Crafters (typically styled CubCrafters) is the leading designer and manufacturer of light-sport, experimental and Part 23 certified backcountry aircraft. “Yakima, Washington-based CubCrafters has spent decades appealing to those who want to fly themselves by designing, building, testing, and selling best-of-class backcountry airplanes modeled on the classic Piper PA-18 Super Cub light aircraft, and the company’s own Cub-derived newly manufactured designs. CubCrafters offers various models of aircraft that fit under FAA Certified (Part 23), Light Sport Aircraft (‘LSA’), and Experimental Amateur Built (‘E/A-B’) classifications. CubCrafters sells finished aircraft as well as aircraft kits for experimental plane enthusiasts who enjoy the hands-on, DIY emotion of assembling things themselves,” a recent article reads. “The company focuses on five main product lines – the Carbon Cub SS LSA, Carbon Cub FX EAB, Carbon Cub EX kit, the FAA-certified XCub, and the classic Top Cub… The quality and nimble performance exhibited by the original Carbon Cub made it the best-selling LSA of all time in the United States, according to the company.”

To view the full article, visit https://ibn.fm/RMwBB

About Cub Crafters Inc.

Founded in 1980 by Jim Richmond, CubCrafters’ roots are in the 80+ year history of classic grassroots aviation, but the company’s products and services are innovative and completely modern. CubCrafters designs and manufactures experimental, LSA, and Part 23 certified aircraft. The Carbon Cub family of aircraft redefined expectations for the backcountry flying experience with innovative design, modern materials, powerful engines, and breathtaking performance. The company’s flagship XCub aircraft is offered in both nosewheel and tailwheel configurations, and substantially expands the mission profile of sport utility aircraft with higher speed, longer range and larger payload. The key to CubCrafters’ success is its ability to create unique value in the experience of personal adventure aviation. For more information about the company, visit www.CubCrafters.com.

NOTE TO INVESTORS: The latest news and updates relating to Cub Crafters are available in the company’s newsroom at https://ibn.fm/CUB

NO MONEY OR OTHER CONSIDERATION IS BEING SOLICITED, AND IF SENT IN RESPONSE, WILL NOT BE ACCEPTED. NO OFFER TO BUY THE SECURITIES CAN BE ACCEPTED AND NO PART OF THE PURCHASE PRICE CAN BE RECEIVED UNTIL AN OFFERING STATEMENT FILED BY THE COMPANY WITH THE SEC HAS BEEN QUALIFIED BY THE SEC. ANY SUCH OFFER MAY BE WITHDRAWN OR REVOKED, WITHOUT OBLIGATION OR COMMITMENT OF ANY KIND, AT ANY TIME BEFORE NOTICE OF ACCEPTANCE GIVEN AFTER THE DATE OF QUALIFICATION.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Uranium Energy (NYSE American: UEC), a U.S.-based uranium mining and exploration company, has entered a further amending agreement with UEX Corporation (TSX: UEX) regarding a previously announced acquisition agreement. The previous agreement, made between UEX, UEC and UEC 2022 Acquisition Corp., has been amended on June 23, 2022, and Aug. 5, 2022, and outlines details wherein UEC will acquire all issued and outstanding common shares of UEX by way of a statutory plan of arrangement under the Canada Business Corporations Act. The announcement notes that, under the amended agreement, UEC pro forma ownership changes to 85.7%, compared to previously disclosed at 85.8% on basic share basis. According to the announcement, holders of UEX shares will now receive 0.090 of one common share of UEC for each UEX share held. The amending agreement also increases the fee paid by UEX to UEC if the transaction is terminated under certain circumstances to $9 million. The agreement also noted that UEX will accept proxies for the special meeting of UEX securityholders to approve the transaction. The company noted that the UEX board of directors has unanimously approved the amending agreement; the board also continues to recommend that UEX shareholders and holders of options and restricted share units of UEX vote in favor of the transaction.

To view the full press release, visit https://ibn.fm/rYnCv

About Uranium Energy Corp.

Uranium Energy is America’s leading, fastest-growing uranium mining company listed on the NYSE American. UEC is a pure-play uranium company and is advancing the next generation of low-cost, environmentally friendly in-situ recovery (“ISR”) mining uranium projects. The company has two production-ready, ISR hub-and-spoke platforms in South Texas and Wyoming, anchored by fully licensed and operational processing capacity at the Hobson and Irigaray processing plants. UEC also has seven U.S. ISR uranium projects with all major permits in place. Additionally, the company has other diversified holdings of uranium assets, including one of the largest physical uranium portfolios of U.S. warehoused U3O8; a major equity stake in the only royalty company in the sector, Uranium Royalty Corp; and a pipeline of resource-stage uranium projects in Arizona, Colorado, New Mexico and Paraguay. The company’s operations are managed by professionals with a recognized profile for excellence in their industry, a profile based on many decades of hands-on experience in the key facets of uranium exploration, development and mining. For more information about the company, visit www.UraniumEnergy.com.

NOTE TO INVESTORS: The latest news and updates relating to UEC are available in the company’s newsroom at https://ibn.fm/UEC 

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Investor Summit Group (“ISG”), which has built a reputation for organizing some of North America’s largest and most reputable independent investor conferences, is hosting this week’s Q3 Investor Summit. The event, presented in an easy-to-use and attendee-friendly virtual format, is scheduled for Aug. 16–17, 2022; ISG presents quarterly investment summits that connect carefully curated companies and well-established management teams with qualified investors to further industry networks, explore potential synergies and forge lasting relationships. According to the announcement, the Investor Summit event series focuses on connecting leading small and micro companies with qualified individuals and entities looking to invest in the open market. The Q3 Investor Conference is designed to support companies as they participate in pivotal conversations with high-quality, long-term equity investors and industry colleagues. The event features companies from an array of sectors, including financial services, fintech, crypto, energy, healthcare, new-age materials and technology; investors attending the conference come from large marquee institutional investors and leading family offices as well as private wealth and money managers. “We are living in unprecedented economic times. With inflation raging, rates being hiked and financial markets seeing a sharp downturn, there is growing interest among investors to identify undervalued small and micro-cap companies,” said Investor Summit Group founder Fred Rockwell in the press release. “ISG’s upcoming summit is the perfect platform for young companies offering exceptional value and seasoned investors searching for high-yield plays.”

To register for the event, visit https://ibn.fm/gITLn

To view the full press release, visit https://ibn.fm/LsCmF

About the Investor Summit Group

Investor Summit Group (formerly MicroCap Conference) hosts the largest independent investor conference on the East Coast. Its independence allows conference organizers to focus on customer service and scheduling high-quality meetings between the executives and investors who attend. The ISG team sets the bar for quality service in a space traditionally dominated by banks that focus more on selling their services than on building the connections companies need to succeed. ISG has facilitated countless valuable interactions for its presenting companies, which have often led to increased exposure, market value appreciation and long-term growth. For more information about this company, visit www.InvestorSummitGroup.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Nemaura Medical (NASDAQ: NMRD), a medical technology company focused on developing and commercializing a daily disposable, wearable glucose sensor and supporting personalized lifestyle coaching programs, has released Q1 2023 financial results for the quarter ending June 30, 2022; the company also noted that it entered into a new note purchase agreement in May 2022 as well as receiving $5 million in proceeds. Financial highlights for the quarter include cash-operating expenses totaling approximately $1.6 million with cash and cash equivalents reach approximately $14.8 million on June 30, 2022, as compared to $17.7 million on March 31, 2022. The report also noted that additional headcount has been added to support the company’s operational scale-up process as well as focus on building product inventory to fulfill existing purchase orders and support ongoing and future commercial sales activities. “We are very pleased with the progress we are steadily making with our manufacturing and commercialization support activities,” said Nemaura Medical CEO Dr. Faz Chowdhury in the press release. “Our daily wearable continuous glucose sensor is unique and innovative, offers lifestyle advantages over competing continuous glucose sensors, and has potential applications for people with diabetes and for the consumer wearable sensor market in general. We continue to build an outstanding team of scientists, manufacturing personnel, engineers and commercial managers to help advance the company to the next phase of maturity and development. Importantly, given the current market climate, we are extremely pleased to have recently raised additional nondilutive funding without any attached warrants or options, further strengthening our balance sheet as we anticipate growing our revenues in the coming quarters.”

To view the full press release, visit https://ibn.fm/ekHrp

About Nemaura Medical Inc.

Nemaura Medical is a medical technology company developing and commercializing noninvasive wearable diagnostic devices. The company is currently commercializing sugarBEAT(R) and proBEAT(TM). sugarBEAT, a CE mark-approved class IIb medical device, is a noninvasive and flexible continuous glucose monitor (“CGM”) that provides actionable insights derived from real-time glucose measurements and daily glucose trend data, which may help people with diabetes and prediabetes to better manage, reverse and prevent the onset of diabetes. Nemaura has submitted a premarket approval application (“PMA”) for sugarBEAT to the U.S. Food and Drug Administration (“FDA”). proBEAT combines noninvasive glucose data processed using artificial intelligence and a digital healthcare subscription service and has been launched in the United States as a general wellness product as part of NMRD’s BEAT diabetes program. Additionally, Nemaura has launched a beta trial of Miboko, a metabolic health and well-being program using a noninvasive glucose sensor along with an AI mobile application that helps a user understand how certain foods and lifestyle habits can impact one’s overall metabolic health and well-being. Nemaura believes that up to half the population could benefit from a sensor and program that monitors metabolic health and well-being. Nemaura sits at the intersection of the global type 2 diabetes market, which is expected to reach nearly $59 billion by 2025, the $50-plus billion prediabetic market and the wearable health-tech sector for weight loss and wellness applications, which is estimated to reach $60 billion by 2023. For more information about the company, visit www.NemauraMedical.com. 

NOTE TO INVESTORS: The latest news and updates relating to NMRD are available in the company’s newsroom at https://ibn.fm/NMRD

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

• CubCrafters, producer of best-in-class Backcountry Aircraft, recently reported it would welcome public investment for the first time in its 42-year history 
• 48 hours after making the announcement, the company indicated that the reservations for its offering (via a Regulation A exemption) had crossed the $5 million mark, representing over 10% of the $50 million goal
• According to the company, the money raised through this public offering is set to go toward increasing production speed, improving service and support for owners of its aircraft, and accelerating innovation
• CubCrafters is eagerly anticipating qualification of the offering by the SEC, which will allow the conversion of the reservations into actual investments

Becoming a publicly-traded company was a long-standing vision of the company Founder, Jim Richmond.  Because of this, Cub Crafters (typically styled CubCrafters), a Yakima, Washington-based OEM designer and producer of backcountry aircraft has now commenced plans to materialize his vision, and is currently allowing potential investors to reserve shares in an upcoming public offering. 

The news that outside investment would be allowed for the first time in the 42 year history of the company excited potential investors, who reserved more than 1,000,000 shares of stock, worth more than $5 million (https://ibn.fm/QZ97i), in just the first 48 hours after the…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to Cub Crafters Inc. are available in the company’s newsroom at https://ibn.fm/CUB

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing innovative treatments for patients suffering from dentofacial abnormalities and/or mild to moderate obstructive sleep apnea (OSA) and snoring in adults, has announced that it will be rescheduling the release of its Q2 2022 financial results, which is for the period ended June 30, 2022; the company will also reschedule the earning conference call related to that report. The company anticipates releasing specific information regarding the updated release dates on or before Aug. 22, 2022; the company had previously announced that the report and conference call would both be Aug. 15, 2022. “The rescheduling is a result of ongoing company analysis and related discussions between the company and its independent registered public accountants regarding certain technical matters pertaining to the company’s revenue recognition policies related to ASC Topic 606,” the company states in the press release.

To view the full press release, visit https://ibn.fm/gEVOq  

About Vivos Therapeutics Inc.

Vivos Therapeutics is a medical technology company focused on developing and commercializing innovative diagnostic and treatment methods for patients suffering from breathing and sleep issues arising from certain dentofacial abnormalities such as mild-to-moderate obstructive sleep apnea (“OSA”) as well as snoring in adults. The Vivos Method represents the first clinically effective, nonsurgical, noninvasive, nonpharmaceutical and cost-effective solution and has proven effective in the treatment of an estimated 28,000 patients worldwide by more than 1,600 trained dentists. The Vivos Method includes the Vivos Complete Airway Repositioning and/or Expansion (“CARE”) appliance therapy and associated protocols that alter the size, shape and position of the tissues that comprise a patient’s upper airway. The Vivos Method opens airway space and may significantly reduce symptoms and conditions associated with mild to moderate OSA, such as lowering Apnea Hypopnea Index scores. Vivos also markets and distributes SleepImage diagnostic technology under its VivoScore program for home sleep testing in adults and children. The Vivos Integrated Practice (“VIP”) program offers dentists training and other value-added services in connection with using the Vivos Method. For more information about this company, visit www.VivosLife.com.  

NOTE TO INVESTORS: The latest news and updates relating to VVOS are available in the company’s newsroom at http://ibn.fm/VVOS

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Nextech (CSE: NTAR) (OTCQB: NEXCF) (FSE: N29), a metaverse company and leading provider of augmented reality (“AR”) experience technologies and 3D model services, today announced its participation in the Q3 Virtual Investor Summit. Nextech AR’s CEO Evan Gappelberg is scheduled to present at 10:15 a.m. ET on Tuesday, Aug.16, 2022, when he will discuss the company’s involvement in 3D modelling for ecommerce and ARway, the disruptive spatial mapping technology for the metaverse. Interested parties should visit https://ibn.fm/6mjXj to register for the webinar. The presentation will be webcast and an archived recording will be made available in the Investors’ section of the Nextech AR website.

To view the full press release, visit https://ibn.fm/Y2GOR

About Nextech AR Solutions Corp.

Nextech is the engine accelerating the growth of the metaverse. Using breakthrough AI, Nextech AR is able to quickly, easily and affordably ARitize (transform) vast quantities and varieties of existing assets at scale making products, people and places ready for interactive 3D use, giving creators at every level all the essential tools they need to build out their digital AR vision in the metaverse. The company’s platform-agnostic tools allow brands, educators, students, manufacturers, creators, and technologists to create immersive, interactive and the most photo-realistic 3D assets and digital environments, compose AR experiences, and publish them omnichannel. With a full suite of end-to-end AR solutions in 3D commerce, education, events, and industrial manufacturing, Nextech AR is in a unique position to meet the needs of the world’s biggest brands and all metaverse contributors. For more information about the company, visit www.NextechAR.com.

NOTE TO INVESTORS: The latest news and updates relating to NEXCF are available in the company’s newsroom at https://ibn.fm/NEXCF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Genprex (NASDAQ: GNPX) is a clinical-stage gene therapy company focused on developing life-changing treatments for patients with cancer and diabetes. The company today announced that the Safety Review Committee (“SRC”) has approved continuation of the Acclaim-1 phase 1/2 clinical trial of REQORSA(TM) in combination with Tagrisso(R) (osimertinib) to treat late-stage non-small cell lung cancer (“NSCLC”) following a review of the first cohort of patients in the phase 1 portion of the trial. In 2020, Genprex received U.S. Food and Drug Administration’s (“FDA”) Fast Track Designation for treatment of the Acclaim-1 patient population. “The SRC approval to advance Acclaim-1 to the higher dose in the second cohort of patients is an important milestone that further supports REQORSA’s safety profile and brings us one step closer to bringing this potentially ground-breaking gene therapy approach to treating NSCLC to the patients who need it most,” said Mark Berger, M.D., chief medical officer of Genprex. “Enrollment in Acclaim-1 remains on track to complete the phase 1 portion of the study by year end.”

To view the full press release, visit https://ibn.fm/HJ5NI

About Genprex Inc.

Genprex is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Genprex’s technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex works with world-class institutions and collaborators to develop drug candidates to further its pipeline of gene therapies in order to provide novel treatment approaches. Genprex’s oncology program utilizes its unique, proprietary, non-viral ONCOPREX(R) Nanoparticle Delivery System, which the company believes is the first systemic gene therapy delivery platform used for cancer in humans. ONCOPREX encapsulates the gene-expressing plasmids using lipid nanoparticles. The resultant product is administered intravenously, where it is then taken up by tumor cells that express proteins that are deficient. The company’s lead product candidate, REQORSA(TM) (quaratusugene ozeplasmid), is being evaluated as a treatment for non-small cell lung cancer (“NSCLC”). REQORSA has a multimodal mechanism of action that has been shown to interrupt cell signaling pathways that cause replication and proliferation of cancer cells; re-establish pathways for apoptosis, or programmed cell death, in cancer cells; and modulate the immune response against cancer cells. In 2020, the U.S. Food and Drug Administration (“FDA”) granted Fast Track Designation for REQORSA for NSCLC in combination therapy with AstraZeneca’s Tagrisso(R) (osimertinib) for patients with EFGR mutations whose tumors progressed after treatment with Tagrisso. In 2021, the FDA granted Fast Track Designation for REQORSA for NSCLC in combination therapy with Merck & Co’s Keytruda(R) (pembrolizumab) for patients whose disease progressed after treatment with Keytruda. For more information, visit the company’s web site at www.Genprex.com.

NOTE TO INVESTORS: The latest news and updates relating to GNPX are available in the company’s newsroom at http://ibn.fm/GNPX

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, is reporting on its financial results for the second quarter 2022; the company also released a corporate and commercial update. Highlights of the report include revenue for the quarter, which totaled 6.2 million, a 17.5% increase from Q2 2021, which was $5.3 million, with six-month year-to-date revenue coming in at $14.2 million, a 60.8% increase over the same period last year. In addition, DRIO reported $55 million in total commercial contract value, noting its continued strong momentum across business-to-business-to-consumer (“B2B2C”) channels. DarioHealth also contracted with a national health plan as a strategic behavioral health partner to support 10 nearly ten million additional members, and DRIO’s strategic partnerships are increasing, a trend that the company anticipates will accelerate, resulting in increased revenue streams from employers and health plans. The company noted its improved financial profile as it completes a shift to become more B2B2C focused. “We are seeing continued contract and revenue growth with several ‘off-cycle’ employer sales, and our previously announced health plans contributing to revenue,” said DarioHealth president of North America Rick Anderson in the press release. “Our collaboration with Sanofi continues to gain traction, as the Sanofi sales organization amplifies our efforts and starts to yield health plan and other strategic opportunities. Similarly, our partnership with Solera Health is off to a strong start, with a large regional health plan in the late contracting phase, offering further evidence of the value that we can drive through our partner channels. Our pipeline is the richest it has been in the company’s history, driven by the breadth and depth of our integrated, multi-chronic condition platform. We anticipate announcing many more customers from our growing pipeline over the remainder of the year.”

To view the full press release, visit https://ibn.fm/I6bmW

About DarioHealth Corp.

DarioHealth is a leading global digital therapeutics company revolutionizing how people with chronic conditions manage their health. DarioHealth offers one of the most comprehensive digital therapeutics solutions on the market, covering multiple chronic conditions including diabetes, hypertension, weight management, musculoskeletal and behavioral health within one integrated technology platform. Dario’s next-generation, AI-powered, digital therapeutic platform supports more than just an individual’s disease. Dario provides adaptive, personalized experiences that drive behavior change through evidence-based interventions, intuitive, clinically proven digital tools, high-quality software, and coaching to help individuals improve health and sustain meaningful outcomes. Dario’s unique user-centric approach to product design and engagement creates an unparalleled experience that is highly rated by users and delivers sustainable results. The company’s cross-functional team operates at the intersection of life sciences, behavioral science, and software technology and utilizes a performance-based approach to improve its users’ health. For more information about the company, please visit www.DarioHealth.com.

NOTE TO INVESTORS: The latest news and updates relating to DRIO are available in the company’s newsroom at http://ibn.fm/DRIO

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Aclarion (NASDAQ: ACON, ACONW) is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (“MRS”), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments. The company is first addressing the chronic low back pain market with Nociscan, the first, evidence-supported, SaaS platform to noninvasively help physicians distinguish between painful and nonpainful discs in the lumbar spine. Through a cloud connection, Nociscan receives magnetic resonance spectroscopy data from an MRI machine for each lumbar disc being evaluated. In the cloud, proprietary signal processing techniques extract and quantify chemical biomarkers demonstrated to be associated with disc pain. Biomarker data is entered into proprietary algorithms to indicate if a disc may be a source of pain. When used with other diagnostic tools, Nociscan provides critical insights into the location of a patient’s low back pain, giving physicians clarity to optimize treatment strategies. For more information, visit the company’s website at www.Aclarion.com.

To view IBN’s virtual coverage of Investor Summit Group’s Q3 Virtual Event, visit  https://ibn.fm/2022InvestorSummitQ3Portal

About InvestorBrandNetwork’s Virtual Coverage

The InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company, is providing the online investment community with a custom-built portal that includes summaries on each of the publicly traded companies participating virtually at this quarter’s Investor Summit. In addition to enabling proficient evaluation of each company via one-click access to market research tools and helpful website links, IBN is using social media and syndicated articles to maximize the visibility of the event.

For more than a decade, IBN has provided real-time coverage for numerous global events and conferences through its various brands, social media accounts and investment newsletters. To further expand visibility of participating companies at these events, and to ensure another successful year for its event collaborations, IBN’s syndication partners have extended digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorBrandNetwork.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer

InvestorBrandNetwork (IBN)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
[email protected]

Embrace Change Acquisition Corp. (NASDAQ: EMCGU), a blank check company newly incorporated as a Cayman Islands exempted company, recently announced the pricing of its initial public offering of 6,500,000 units, each at a price of $10.00, with each unit consisting of one ordinary share, one redeemable warrant and one right. Each redeemable warrant entitles the holder to purchase one ordinary share at a price of $11.50 per share, and each right entitles the holder to acquire one-eighth of an ordinary share. The units have commenced trading on the Nasdaq Global Market under the ticker symbol EMCGU, with the IPO expected to close on Aug. 12, 2022, subject to customary conditions. Once the securities comprising the units begin separate trading, the ordinary shares, warrants and rights are expected to begin trading on the Nasdaq under the symbols EMCG, EMCGW and EMCGR, respectively. EF Hutton, division of Benchmark Investments LLC, is acting as the sole book-running manager, and US Tiger Securities Inc. is acting as the co-manager for the IPO. Embrace Change Acquisition Corp. has granted the underwriters a 45-day option to purchase up to 975,000 additional units at the IPO price to cover over-allotments, if any.

To view the full press release, visit https://ibn.fm/TeQpO

About Embrace Change Acquisition Corp.

The company is a blank check company, also commonly referred to as a special purpose acquisition company, or SPAC, formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or other similar business combination with one or more businesses. The company’s efforts to identify a prospective target business will not be limited to a particular business, industry, sector or geographical region, although the company will not consider or undertake a business combination with an entity or business based in, or with its principal or a majority of its business operations (either directly or through any subsidiaries) in, the People’s Republic of China (including Hong Kong and Macau), and, for the avoidance of doubt, it will not enter into an agreement for, or consummate its initial business combination with, such an entity or business, or consummate its initial business combination in circumstances where it is the counterparty to a VIE or other arrangement with a China-based entity. The company is led by its Chairman of the Board and Chief Executive Officer Yoann Delwarde and Chief Financial Officer Zheng Yuan.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Processa Pharmaceuticals (NASDAQ: PCSA), a clinical-stage company developing drugs for patients who have unmet medical conditions that require better treatment options to improve a patient’s survival and/or quality of life, is reporting financial numbers and clinical program updates for the quarter ended June 30, 2022. Highlights of the report include news that PCSA’s PCS12852  program is on target to complete enrollment by September and that expanded efforts to increase enrollment in PCS 499 and PCS 6422 are showing results. The company also reported a cash balance on June 30, 2022, of $12.1 million, which PCSA expects to be sufficient to complete its three ongoing clinical trials and fund operations into the third quarter of 2023. “Our efforts to enhance enrollment through adding new sites, extensive marketing campaigns and working with our CRO partners are showing results,” said Processa president and CEO Dr. David Young in the press release. “We expect to close out enrollment for PCS12852 for gastroparesis within the next month and present top-line data from the trial before the end of the year. We now have a sufficient number of patients in the screening queue for PCS6422 to complete our interim cohorts, which we believe will provide valuable insights on de novo formation of DPD. We anticipate we will determine the maximum tolerated dose by early 2023. Patients are beginning to show a willingness to travel, and we are seeing increased patient activity in our PCS499 ulcerative necrobiosis lipoidica (uNL) trial. We are optimistic that we will enroll our interim analysis cohort before the end of the year. [And] as part of our efforts to increase enrollment on our PCS499 trial, we recently launched a website to increase awareness of uNL and to inform patients of the ongoing phase 2B study of PCS499. Advancing these three drugs in their respective clinical trial allows us to obtain the clinical data to better define each pivotal trial as well as provide us with more insight into how FDA will review each of these products when we submit the New Drug Applications to FDA.”

To view the full press release, visit https://ibn.fm/FQU6f

About Processa Pharmaceuticals Inc.

The mission of Processa is to develop products with existing clinical evidence of efficacy for patients with unmet or underserved medical conditions who need treatment options that improve survival and/or quality of life. The company uses these criteria for selection to further develop its pipeline programs to achieve high-value milestones effectively and efficiently. Active clinical pipeline programs include Next Generation Capecitabine (formerly identified as PCS6422) for metastatic colorectal cancer and breast cancer program; PCS499 (“PCS499”), an ulcerative necrobiosis lipoidica program; and PCS12852 (“PCS12852”) (a GI motility/gastroparesis program). The members of the Processa development team have been involved with more than 30 drug approvals by the FDA, including drug products targeted to orphan disease conditions, and more than 100 FDA meetings throughout their careers. For more information, visit the company’s website at www.ProcessaPharma.com. 

NOTE TO INVESTORS: The latest news and updates relating to PCSA are available in the company’s newsroom at https://ibn.fm/PCSA

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

AgriFORCE Growing Systems (NASDAQ: AGRI) is an AgTech company focused on the development and acquisition of crop production know-how and intellectual property augmented by advanced AgTech facilities and solutions. Looking to serve the global market, the company’s current focus is on North America, Europe and Asia. The AgriFORCE vision is to be a leader in delivering plant-based foods and products through advanced and sustainable AgTech solution platforms that make positive change in the world—from seed to table. The AgriFORCE goal: Clean. Green. Better. For more information, visit the company’s website at www.agriforcegs.com.

To view IBN’s virtual coverage of Investor Summit Group’s Q3 Virtual Event, visit  https://ibn.fm/2022InvestorSummitQ3Portal

About InvestorBrandNetwork’s Virtual Coverage

The InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company, is providing the online investment community with a custom-built portal that includes summaries on each of the publicly traded companies participating virtually at this quarter’s Investor Summit. In addition to enabling proficient evaluation of each company via one-click access to market research tools and helpful website links, IBN is using social media and syndicated articles to maximize the visibility of the event.

For more than a decade, IBN has provided real-time coverage for numerous global events and conferences through its various brands, social media accounts and investment newsletters. To further expand visibility of participating companies at these events, and to ensure another successful year for its event collaborations, IBN’s syndication partners have extended digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorBrandNetwork.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer

InvestorBrandNetwork (IBN)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
[email protected]

Auddia (NASDAQ: AUUD) is reinventing how consumers engage with audio through the development of a proprietary AI platform for audio and innovative technologies for podcasts. Auddia offers two industry firsts-the ability to listen to any AM/FM radio station with added personalized content and no commercials, as well as podcasts with an interactive digital feed that supports deeper stories and delivers digital revenue to podcasters. Both offerings address large and rapidly growing audiences with strong purchase intent. For more information, visit the company’s website at www.Auddia.com.

To view IBN’s virtual coverage of Investor Summit Group’s Q3 Virtual Event, visit  https://ibn.fm/2022InvestorSummitQ3Portal

About InvestorBrandNetwork’s Virtual Coverage

The InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company, is providing the online investment community with a custom-built portal that includes summaries on each of the publicly traded companies participating virtually at this quarter’s Investor Summit. In addition to enabling proficient evaluation of each company via one-click access to market research tools and helpful website links, IBN is using social media and syndicated articles to maximize the visibility of the event.

For more than a decade, IBN has provided real-time coverage for numerous global events and conferences through its various brands, social media accounts and investment newsletters. To further expand visibility of participating companies at these events, and to ensure another successful year for its event collaborations, IBN’s syndication partners have extended digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorBrandNetwork.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer

InvestorBrandNetwork (IBN)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
[email protected]

Friendable (OTC: FDBL), a mobile technology and marketing company, announced its acquisition of Artist Republik and FeaturedX in January 2022, bringing together a 360-degree suite of services for artists. The acquisition completed the company’s flagship offering, Fan Pass Live. “Artists can now sign up for the Fan Pass Live artist platform and benefit from music production, distribution and marketing services without the control of music labels pulling the strings or eating up revenue… The 360-degree suite of Fan Pass Live, Artist Republik and FeaturedX promotes being an independent label in an artist’s pocket, meaning there are no gatekeepers, no middleman, and artists retain 100% control of their music,” a recent article reads. “With our 360 offering, including Artist Republik services, FeaturedX and Fan Pass Live, each artist can continue monetizing from the fan engagement created by our promotion, further gathering more content, traffic and revenue for the company overall,” Friendable CEO Robert A. Rositano Jr. is quoted saying.

To view the full article, visit https://ibn.fm/FuoxY

About Friendable Inc.

Friendable is a mobile technology and marketing company focused on developing and identifying products, services and brand opportunities with mass market potential and scalability. Friendable published its first mobile application in the Apple App Store and Google Play Store in 2014 in the social networking and dating category. The Friendable app achieved over 1.5 million downloads, top 10 worldwide rankings, and has led to celebrity-related marketing opportunities and various relationships with well-known music artists as well as up-and-coming independent artists. Friendable has since pivoted its business focus to its music artist offering, a one-of-a-kind 360 artist platform. The offering now includes music production/collaboration, music distribution (Spotify, SoundCloud, Play Listing, livestream/live events, promotions, ticket sales, behind the scenes, merch designs/store/ship, tips, fan interaction, subscription offerings and more, which all equal revenue sharing and earning for all music artists. It is the company’s goal to become the new launch point for indie artists, as well as artists at all levels, as they build engagement, revenue and fans/followers. Launched July 24, 2020, the Fan Pass livestream platform has proven invaluable for artists and fans alike as performances shifted from the stage to the screen, with its acquisition of Artist Republik and FeaturedX in January 2022. Friendable was founded by brothers Robert A. Rositano Jr. and Dean Rositano, who have more than 27 years of experience working together on technology-related ventures. For more information, visit https://ir.Friendable.com, www.FanPassLive.com, www.ArtistRepublik.com and www.FeaturedX.com.

NOTE TO INVESTORS: The latest news and updates relating to FDBL are available in the company’s newsroom at http://ibn.fm/FDBL

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Khiron Life Sciences (OTCQX: KHRNF) is a leading vertically integrated international medical cannabis corporation with core operations in Latin America and Europe. Leveraging medical health clinics and proprietary telemedicine platforms, Khiron combines a patient-oriented approach, physician education programs, scientific, product innovation, and cannabis operations expertise to drive prescriptions and brand loyalty with patients worldwide. The company has a sales presence in Colombia, Peru, Germany, United Kingdom, and Brazil and is positioned to commence sales in Mexico. The Company is led by co-founder and Chief Executive Officer, Alvaro Torres, together with an experienced and diverse executive team and Board of Directors. For more information, visit the company’s website at https://investors.khiron.ca.

To view IBN’s virtual coverage of Investor Summit Group’s Q3 Virtual Event, visit  https://ibn.fm/2022InvestorSummitQ3Portal

About InvestorBrandNetwork’s Virtual Coverage

The InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company, is providing the online investment community with a custom-built portal that includes summaries on each of the publicly traded companies participating virtually at this quarter’s Investor Summit. In addition to enabling proficient evaluation of each company via one-click access to market research tools and helpful website links, IBN is using social media and syndicated articles to maximize the visibility of the event.

For more than a decade, IBN has provided real-time coverage for numerous global events and conferences through its various brands, social media accounts and investment newsletters. To further expand visibility of participating companies at these events, and to ensure another successful year for its event collaborations, IBN’s syndication partners have extended digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorBrandNetwork.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer

InvestorBrandNetwork (IBN)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
[email protected]

Cub Crafters (typically styled CubCrafters), the leading designer and manufacturer of light-sport, experimental and Part 23 certified backcountry aircraft, was featured in a recent article published by the APOA Foundation. The piece highlights CubCrafters’ unveiling of its Carbon Cub EX–2 engine upgrade, as well as its plan to raise millions to speed up production and aircraft development. The article reads, “CubCrafters Vice President of Sales and Marketing Brad Damm said customers asked for a fuel-injected variant with a fixed-pitch propeller: ‘So, this is a new engine for us. Based on the previous IO-360 engine that we had. We’ve lightened it up a bunch and we’ve set it up for a fixed-pitch propeller instead of a constant-speed propeller.’ … Although there were several noticeable differences—a shorter takeoff roll, steeper climb rate and faster cruise speed—the aircraft retained the smooth, refined feel and responsiveness that Carbon Cubs are known for… ‘I think demand is going to be huge for it,’ said Damm. ‘Customers have been asking for it for a long time. We’ve had it out here all week. Lots of people have looked at it. Lots of people have been excited about it…We just can’t build airplanes quite as fast as people want to buy them.’ In addition to announcing a new Lycoming retrofit, CubCrafters also announced that as of July 25, investors can enter into a nonbinding reservation to buy shares of CubCrafters. For the first time in the company’s 40-year history, public investment will be allowed under Securities and Exchange Commission (‘SEC’) Regulation A. CubCrafters is expected to file with the SEC for qualification within weeks.”

To view the full press release, visit https://ibn.fm/tGHpa

About Cub Crafters Inc.

Founded in 1980 by Jim Richmond, CubCrafters’ roots are in the 80+ year history of classic grassroots aviation, but the company’s products and services are innovative and completely modern. CubCrafters designs and manufactures experimental, LSA, and Part 23 certified aircraft. The Carbon Cub family of aircraft redefined expectations for the backcountry flying experience with innovative design, modern materials, powerful engines, and breathtaking performance. The company’s flagship XCub aircraft is offered in both nosewheel and tailwheel configurations, and substantially expands the mission profile of sport utility aircraft with higher speed, longer range and larger payload. The key to CubCrafters’ success is its ability to create unique value in the experience of personal adventure aviation. For more information about the company, visit www.CubCrafters.com.

NOTE TO INVESTORS: The latest news and updates relating to Cub Crafters are available in the company’s newsroom at https://ibn.fm/CUB

NO MONEY OR OTHER CONSIDERATION IS BEING SOLICITED, AND IF SENT IN RESPONSE, WILL NOT BE ACCEPTED. NO OFFER TO BUY THE SECURITIES CAN BE ACCEPTED AND NO PART OF THE PURCHASE PRICE CAN BE RECEIVED UNTIL AN OFFERING STATEMENT FILED BY THE COMPANY WITH THE SEC HAS BEEN QUALIFIED BY THE SEC. ANY SUCH OFFER MAY BE WITHDRAWN OR REVOKED, WITHOUT OBLIGATION OR COMMITMENT OF ANY KIND, AT ANY TIME BEFORE NOTICE OF ACCEPTANCE GIVEN AFTER THE DATE OF QUALIFICATION.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Save Foods (NASDAQ: SVFD) (FSE: 80W) is an agri-food tech company specializing in eco crop protection that helps reduce food waste and ensure food safety while reducing the use of pesticides. The company today announced the initiation of seven commercial pilots with leading Peruvian exporters, such as Agricola Cerro Prieto (“ACP”) and another multinational packer. Under the pilots, Save Foods’ innovative treatments will be evaluated for their impact on avocados, berries and citrus fruits. “We are proud and excited to test our treatments with these companies. Our business strategy centers around countries that export to Europe and involve a long export journey, frequently consisting of thousands of miles,” said CEO of Save Foods’ Israeli subsidiary, Dan Sztybel. “Keeping produce fresh for such long journeys is likely to require the use of pesticides, which are being banned in accordance with EU’s ‘ farm to fork ’ initiative. This is where our competitive edge helps us — we can ensure businesses are EU-compliant because our treatments extend shelf life while reducing the use pesticides.”

To view the full press release, visit https://ibn.fm/AOhtW

About Save Foods Inc.

Save Foods is an innovative, dynamic company addressing two of the most significant challenges in the agri-food tech industry: food waste and loss and food safety. The company is dedicated to delivering integrated solutions for improved safety, freshness and quality, every step of the way from field to fork. Collaborating closely with its customers, Save Foods develops new solutions that benefit the entire supply chain and improve the safety and quality of life of both workers and consumers alike. Its initial applications are in post-harvest treatments in fruit and vegetable packing houses that process produce including citrus, avocado, pears, apples and mangos. By controlling and preventing pathogen contamination and significantly reducing the use of hazardous chemicals and their residues, Save Foods’ treatments not only prolong fresh produce shelf life and reduce food loss and waste, but they also ensure a safe, natural and healthy product. For more information, visit the company’s website at www.SaveFoods.co.

NOTE TO INVESTORS: The latest news and updates relating to SVFD are available in the company’s newsroom at https://ibn.fm/SVFD   

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, has presented results from its recent research showing impact of DRIO solutions to support people living in rural areas by delivering lasting health improvements. According to the presentation, the research focused on Dario’s ability to improve the health of members in rural areas, comparing results with those from urban counterparts; the results showed the solutions were equally effective. The information was presented at the Association of Diabetes Care and Education Specialists (“ADCES”) annual conference this week. In the announcement, the company noted living in rural areas is often associated with poor health, which can be aggravated by having less access to care and dealing with lower socioeconomic status. Dario’s integrated suite of chronic condition solutions helps people manage their health and care between doctors’ visits, a feature that could be highly beneficial for those living in rural areas. Dario’s research examined blood glucose data from members with high-risk type 2 diabetes living in urban areas to members living in rural areas and compared average levels of glycemic control over time; results indicated that both groups significantly reduced and maintained their average blood glucose levels, with no statistical difference between the rural and nonrural members. “Digital health represents an enormous opportunity to democratize access to better health if we build solutions that acknowledge the unique experiences of people across the country, including those outside of urban and suburban areas,” said Dario chief medical officer Omar Manejwala, MD, in the press release. “This new research shows Dario has potential to greatly improve self-care in rural populations by providing digital health tools that speak to individuals in relevant and meaningful ways no matter their location.”

To view the full press release, visit https://ibn.fm/kEy3p

About DarioHealth Corp.

DarioHealth is a leading digital therapeutics (“DTx”) company revolutionizing how people with chronic conditions manage their health through a user-centric, multichronic condition platform. The company’s platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain and behavioral health. DRIO’s user-centric platform offers people continuous and customized care for health, disrupting the traditional episodic approach to healthcare. This approach empowers people to holistically adapt their lifestyles for sustainable behavior change, driving exceptional user satisfaction, retention and results. Dario provides its highly user rated solutions globally to health plans and other payors, self-insured employers, providers of care and directly to consumers. For more information about the company, please visit www.DarioHealth.com.

NOTE TO INVESTORS: The latest news and updates relating to DRIO are available in the company’s newsroom at http://ibn.fm/DRIO

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Investor Summit Group (“ISG”) has partnered with InvestorBrandNetwork (“IBN”), an innovative corporate communications agency and diversified content distributor, again this year. IBN will be an official media sponsor for ISG’s virtual Q3 Virtual Summit; the event is scheduled to be held Aug. 16–17, 2022. ISG has built a reputation for its events, which facilitate collaborative partnerships between leading investors and innovative small and micro-cap companies. ISG’s upcoming Q3 Virtual Summit is designed to host cutting-edge companies and highly active qualified investors, including financial institutions, family offices, private wealth managers and seasoned money managers; during the event, investors and companies will explore technological synergies and build long-term partnerships. This year’s Q3 summit is expected to bring together nearly 70 high-quality companies and more than 600 attendees, including some of the most revolutionary corporate management teams in industries as diverse as financial services, fintech, crypto, energy, healthcare, new-age materials and technology. The summit agenda includes live presentations, informative webcasts, 1-to-1 closed-door meetings, personalized technology training and great networking opportunities. IBN has worked with ISG before to provide event corporate communications. For the Q3 Virtual Summit, IBN will work  to increase market awareness and strengthen the recognition of conference participants. “IBN will leverage its media capabilities and digital infrastructure to provide a strong virtual presence that heightens the visibility of companies participating in the upcoming virtual summit,” said IBN communications director Jonathan Keim in the press release. “We are pleased to work alongside the highly professional team at ISG once again.”

To view the full press release, visit https://ibn.fm/1NCUG

About the Investor Summit Group

The Investor Summit Group (“ISG”) is an independent company focused on providing networking opportunities to the micro-cap and small-cap communities at large. As an independent event, ISG focuses on creating a unique network of the highest-quality investors and the most valuable micro-cap and small-cap companies. ISG hosts invite-exclusive events, with each invited company being carefully selected based on strong fundamentals and growth prospects. It is an opportunity to be introduced to and speak with management at some of the most attractive companies, to ask questions to subject matter experts, and to mingle with buyside analysts and other micro-cap and small-cap investors in one-on-one meetings. For more information about this company, visit www.InvestorSummitGroup.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Helius Medical Technologies (NASDAQ: HSDT), a neurotech company focused on neurological wellness, announced the pricing of a public offering of 24,000,000 shares of its Class A common stock (or common stock equivalents in lieu thereof) and warrants to purchase up to 36,000,000 shares of its Class A common stock (“public warrants”) at a purchase price of $0.75 per share and associated public warrant. According to the update, the public warrants will have an exercise price of $0.75 per share, are exercisable upon issuance, and will expire five years following the date of issuance. Roth Capital Partners acted as lead placement agent for the offering, which closed on Aug. 9, 2022.

To view the full press release, visit https://ibn.fm/LFsKI

About Helius Medical Technologies Inc.

Helius Medical Technologies is a neurotech company focused on neurological wellness. The company’s purpose is to develop, license and acquire unique and non-invasive platform technologies that amplify the brain’s ability to heal itself. The company’s commercial product is the Portable Neuromodulation Stimulator (PoNS(TM)). For further information about the company, please visit www.HeliusMedical.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Uranium Energy (NYSE American: UEC) today announced that it has filed a Technical Report Summary (“TRS”) on EDGAR, disclosing mineral resources for its Texas hub-and-spoke in-situ recovery (“ISR”) project. “The disclosure of resources in the new S-K 1300 format at our South Texas hub-and-spoke production platform reconfirms the robust nature of the project,” said Amir Adnani, president and CEO of Uranium Energy. “Our database of drilling results, containing decades of exploration logs, shows strong potential for project expansion and also dovetails well with our initiative to increase the production license at the Hobson Plant. We are pleased with the progress of the company’s domestic ISR profile in Texas and Wyoming as we continue to advance these projects towards near term production. UEC has recently submitted an offer to the U.S. government to supply the uranium reserve (‘UR’), and we are looking forward to our production-ready projects providing future needs of the UR as well as the utility industry.”

To view the full press release, visit https://ibn.fm/fVTGH

About Uranium Energy Corp.

Uranium Energy is America’s leading, fastest growing, uranium mining company listed on the NYSE American. UEC is a pure-play uranium company and is advancing the next generation of low-cost, environmentally friendly in-situ recovery (“ISR”) mining uranium projects. The company has two production-ready ISR hub-and-spoke platforms in South Texas and Wyoming, anchored by fully licensed and operational processing capacity at the Hobson and Irigaray plants. UEC also has seven U.S. ISR uranium projects with all of their major permits in place. Additionally, the company has other diversified holdings of uranium assets, including: (1) one of the largest physical uranium portfolios of U.S. warehoused U3O8 ; (2) a major equity stake in the only royalty company in the sector, Uranium Royalty Corp.; and (3) a pipeline of resource-stage uranium projects in Arizona, Colorado, New Mexico and Paraguay. The company’s operations are managed by professionals with a recognized profile for excellence in their industry, a profile based on many decades of hands-on experience in the key facets of uranium exploration, development and mining. For more information about the company, visit www.UraniumEnergy.com.

NOTE TO INVESTORS: The latest news and updates relating to UEC are available in the company’s newsroom at https://ibn.fm/UEC

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

VistaGen Therapeutics (NASDAQ: VTGN), a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other central nervous system (CNS) disorders, is reporting its financial results for Q1 2023, or the period ended June 30, 2022. In addition, the company also released a corporate update for the company, noting that evaluation of its proprietary PALISADE-1 continues with interim analysis of PALISADE-2 beginning. The company also stated that preliminary data from some 200 subjects in the PALISADE open-label safety study suggests that continued use of POAI’s PH94B as needed has potential to achieve cumulative functional improvement in the severity of social anxiety disorder (“SAD”). “We remain steadfast in our commitment to change the trajectory of mental health care for millions of people affected by anxiety and depression disorders,” said VistaGen CEO Shawn Singh in the press release. “While we examine the results of our PALISADE-1 Phase 3 study in social anxiety disorder, we have paused enrollment in our PALISADE-2 Phase 3 study and have engaged an independent biostatistician to conduct an interim analysis of data collected to date. We then plan to meet with the FDA to pursue a consensus path forward for further phase 3 development of PH94B in social anxiety disorder. . . . We continue to believe in PH94B’s potential to help individuals suffering from social anxiety disorder. We are further encouraged by preliminary data from a cohort of nearly 200 patients in our PALISADE open-label safety study who have completed three months of acute, as-needed use of PH94B. These preliminary data suggest that repeated acute, as-needed use of PH94B over an extended period of time has potential to increasingly relieve symptoms of social anxiety disorder, as measured by the Liebowitz Social Anxiety Scale, or LSAS, which historically has been the diagnostic gold standard for clinical assessment of social anxiety disorder. . . . Our mission is to transform lives, and we have a strong pipeline and team in place to accomplish that goal.”

To view the full press release, visit https://ibn.fm/xU7st

About VistaGen Therapeutics Inc.

VistaGen is a late clinical-stage, CNS-focused, biopharmaceutical company striving to transform the treatment landscape for individuals living with anxiety, depression and other CNS disorders. The company is advancing therapeutics with the potential to be faster acting and with fewer side effects and safety concerns than those that are currently available. VistaGen’s clinical-stage candidates are targeting multiple forms of anxiety and depression. PH94B and PH10 belong to a new class of drugs known as pherines, which are odorless and tasteless investigational neuroactive steroids designed with a novel rapid-onset mechanism of action that activates chemosensory neurons in the nasal passages and can impact the olfactory-amygdala neural circuits without systemic uptake or direct activity on CNS neurons in the brain. VistaGen is passionate about transforming mental-health care and redefining what is possible in the treatment of anxiety and depression. For more information about the company, please visit www.VistaGen.com.

NOTE TO INVESTORS: The latest news and updates relating to VTGN are available in the company’s newsroom at https://ibn.fm/VTGN

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, is reporting its numbers for second quarter 2022, or the period ended June 30, 2022. According to the announcement, the report indicates a strong balance sheet with a solid cash balance, commensurate equity and no debt. Highlights from the quarter include the commercialization launch of PeDAL, POAI’s innovative AI product, along with the company’s presence at BIO International, which included one-on-one partnering meetings with pharmaceutical and biotech companies; the appointment of Julia Kirshner, PhD, as chief scientific officer; the consolidation and expansion of POAI’s research and development team with TumorGenesis moving to Pittsburg; and a 12% increase of cash and equivalents from $25 million on March 31, 2022, to $28 million at quarter end. Other financial numbers for the quarter include net sales revenue of $0.4 million for the quarter, an increase of 6% from the same three-month period in 2021; gross profit margin for the company growing from 59% in Q2 2021 to 64% for Q2 2022; net cash used in operating activities totaling $6.4 million for the six months ended June 30, 2022; and general and administrative expenses totaling $2.4 million, up from $2.1 million in the quarter ended June 30, 2021. In addition, POAI’s quarterly sales and marketing expenses increased to $0.3 million for the quarter, up by $0.1 million from the same quarter in 2021. The company also announced a shareholder earnings webcast to be held Friday, Aug. 12, 2022, at 12 p.m. ET.

To view the full webcast, visit https://ibn.fm/CLjK7

To view the full press release, visit https://ibn.fm/UgEac

About Predictive Oncology Inc.

Predictive Oncology is a knowledge-driven company, applying artificial intelligence to develop personalized cancer therapies that improve patient outcomes. The company, which offers a suite of solutions for oncology drug development, operates through four segments (Skyline, Helomics, zPREDICTA and Soluble), which covers five subsidiaries: Helomics, zPREDICTA, Soluble Biotech, TumorGenesis and Skyline Medical. Helomics Holding Corporation is involved in applying artificial intelligence (“AI”) in the company’s precision medicine business, to offer AI-driven predictive models of tumor drug response to enhance clinical results for patients and to aid diagnostic, biotech and pharmaceutical companies in new personalized diagnostic and drug development. Skyline Medical Inc. sells the STREAMWAY System(R), a fully automated wall-mounted product that is utilized to dispose of an unlimited quantity of suction fluid in an operating room setting. It offers continuous performance for medical practitioners by effectively eradicating the healthcare professional’s exposure to potentially infectious liquids gathered during surgical and other medical operations. Soluble Biotech Inc. is involved in research and commercialization focused on protein production, stability studies and solubility improvements. zPREDICTA Inc. does tumor-specific research using in vitro models for oncology and drug development. TumorGenesis serves as the company’s arm for research and development for zPREDICTA, Soluble and Helomics. This subsidiary is also involved in cellular media kit production, which aids cancer cells to grow outside the body of patients while preserving their proteomic and RNA/DNA signatures. For more information about the company, please visit www.Predictive-Oncology.com.

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Sustain Southern California (“Sustain SoCal”) today announced that it will host the Water Solutions 7 (“WS7″) Conference on Thursday, Aug. 25, 2022. The premier event, to be held in person at UCI Beall Applied Innovation in Irvine, will focus on real-life strategies and cutting-edge innovation to ensure sufficient and affordable water supplies in Southern California and the surrounding regions. “The Water Solutions event series is now in its 7th iteration. It has consistently offered an exciting platform for students, professionals and the general public, whose support we appreciate very much,” said Scott Kitcher, president and CEO of Sustain SoCal. “At Sustain SoCal, we are dedicated to contributing to the sustainability and economic discourse in the Southern California region and beyond. By being strategically located at UCI Beall Applied Innovation, we have been privileged to enable collaboration between world-class university resources and industry professionals in the water supply and allied sectors for more than a decade.”

To view the full press release, visit https://ibn.fm/wqsZA

About Sustain SoCal

Sustain SoCal, a non-profit organization, accelerates sustainability and economic growth through innovation, collaboration and education in Southern California. The organization has a ten-year history in exploring and implementing pragmatic, real-world solutions to the challenges created by growth, change and inefficiency. It conducts conferences, workshops and networking events that lead to initiatives that positively impact the region’s economic progress and sustainability. For more information, please visit www.SustainSoCal.org.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

SPYR (OTCQB: SPYR), a diversified technology company developing products and leveraging the Internet of Things (“Iot”) for consumer use and large-scale applications and industries, and its subsidiary GeoTraq, were mentioned in a recent Emerging Markets Report. The report noted that SPYR focus is developing, marketing and positioning the GeoTraq small transmitter tracking devices, including the company’s newest offering, the Micro-Tracker(R), as the leading edge of IoT asset tracking technology. The announcement noted that these proprietary tracking devices can be used to monitor and track everything from Porta-Potties at major music festivals to locating construction assets at a job site; the devices are also designed to mission-critical information about valuable supply chain assets monitoring temperature, flow, pressure, humidity, motion, acceleration and more. The report also noted that SPYR’s ambitions are not limited to its goals to market and sell the GeoTraq Micro-Tracker, which includes rolling out the device in Q1 or Q2 2023. “SPYR’S plans include the development and deployment of its Micro-Tracker, the next generations of GeoTraq’s tracking tech,” the report stated. “SPYR is upgrading its communication technology to a state-of-the-art cell location technology that will provide Micro-Tracker customers with two advantages: First, the new technology will provide a significant improvement in position accuracy of the device and the asset it tracks. . . . Just as important as location accuracy, the Micro-Tracker technology has a much faster position acquisition time.”

To view the full press release, visit https://ibn.fm/IHcXq

About SPYR Inc.

SPYR Technologies is a technology company that, through its subsidiary Applied Magix Inc., develops and resells Apple(R) ecosystem-compatible products with an emphasis on the growing multibillion-dollar IoT smart-home and connected-car markets. Through its GeoTraq business, SPYR develops and manufactures entirely self-contained, ultra-small mobile Internet of Things (“IoT”) modules including Trackertracker-M modules for asset tracking and location-based services and Sensorsensor-M modules used for remote monitoring. SPYR continues to identify and target acquisitions that will grow its footprint in the industry and expand the products it offers consumers, including companies developing artificial intelligence (“AI”) and smart-technology products. For more information about this company, visit https://ir.spyr.com.

NOTE TO INVESTORS: The latest news and updates relating to SPYR are available in the company’s newsroom at https://ibn.fm/SPYR

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Pressure BioSciences (OTCQB: PBIO) (“PBI”) is a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and specialty testing services to the worldwide biopharmaceuticals and other industries. The company today announced approval for its South Easton, Massachusetts, facility to manufacture custom, compliant, hemp-derived CBD nanoemulsions under the processing/manufacturing license of its commercial partner, Canopy CBD Farms (“CCF”). CFF is a Massachusetts-licensed hemp processing and manufacturing company. “I am delighted to partner with PBI by extending my CBD processing and manufacturing license to PBI’s South Easton location,” said John Westlake, founder and president of CCF. “I firmly believe I can leverage my many years in the cannabis market and hundreds of industry connections to help PBI get quickly and efficiently to market with their unique, highly stable and water-soluble hemp-derived CBD nanoemulsions, processed using their world-class UST platform.”

To view the full press release, visit https://ibn.fm/r0Pjd

About Pressure BioSciences Inc.

Pressure BioSciences is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences and other industries. The company’s products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or “PCT”) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to control bio-molecular interactions safely and reproducibly (e.g., cell lysis, biomolecule extraction). The company’s primary focus is the development of PCT-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil and plant biology, forensics, and counter-bioterror applications. Additionally, major new market opportunities have emerged in the use of its pressure-based technologies in the following areas: (1) recently acquired, patented technology from BaroFold Inc. (the BaroFold technology) to allow entry into the bio-pharma contract services sector, and (2) recently-patented, scalable, high-efficiency, pressure-based Ultra Shear Technology (“UST”) platform to (i) create stable nanoemulsions of otherwise immiscible fluids (e.g., oils and water) and to (ii) prepare higher quality, homogenized, extended shelf-life or room temperature stable low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies. For more information about the company, visit www.PressureBioSciences.com.

NOTE TO INVESTORS: The latest news and updates relating to PBIO are available in the company’s newsroom at http://ibn.fm/PBIO

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Playgon Games (TSX.V: DEAL) (OTCQB: PLGNF) (FSE: 7CR), a propriety SaaS technology company delivering “state-of-the-art” mobile live dealer technology and eTable games to online gaming operators globally, announced that it is working with independent testing laboratory Gaming Laboratories International(R) (“GLI”). According to the company, GLI provides world-class testing, certification and professional services to the global gaming industry’s suppliers, regulators and operators across more than 480 jurisdictions. According to the announcement, the company successfully received certification for live dealer studio in accordance with GLI-19, Isle of Man and Ontario technical requirements, thereby better positioning the company for pending commercial agreements licensed in those jurisdictions. The company explained that it partnered with GLI to complete GLI-19 Interactive Gaming Systems testing and audit requirements for its Las-Vegas-based live dealer studio as well as to evaluate Playgon’s technology with requirements from additional jurisdictions that will be driven by commercial customer agreements. The company noted that additional jurisdictions will be completed over time and in stages as future customer launches occur. “Adding Ontario and Isle of Man certifications and continuing to work with GLI to certify other jurisdictions further strengthens our global footprint and strategy,” said Playgon Games CEO Darcy Krogh in the press release.

To view the full press release, visit https://ibn.fm/8qpHu

About Playgon Games Inc.

Playgon is a SaaS technology company focused on developing and licensing digital content for the growing iGaming market. The company provides a multitenant gateway that allows online operators the ability to offer their customers innovative iGaming software solutions. Its current software platform includes Live Dealer Casino, E-Table games and Daily Fantasy Sports, which, through a seamless integration at the operator level, allows customer access without having to share or compromise any sensitive customer data. As a true business-to-business digital content provider, Playgon products are ideal turnkey solutions for online casinos, sportsbook operators, land-based operators, media groups and big database companies. For more information about the company, please visit www.Playgon.com. 

NOTE TO INVESTORS: The latest news and updates relating to PLGNF are available in the company’s newsroom at https://ibn.fm/PLGNF  

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

iClick (NASDAQ: ICLK) is a leading enterprise and marketing cloud platform in China that empowers worldwide brands with full-stack consumer lifecycle solutions. The company today announced that it will report its unaudited second quarter 2022 financial results before the U.S. market opens on Thursday, Aug. 25, 2022. Jian “T.J.” Tang, iClick’s chairman, chief executive officer and co-founder, and David Zhang, chief financial officer, will host a conference call to discuss the company’s business and financial performance at 8:00 a.m. U.S. Eastern Time (8:00 p.m. Hong Kong Time) on Aug. 25. Interested parties may join the call by pre-registering at https://ibn.fm/LFzj8 and utilizing the dial-in numbers, passcode and unique access PIN that will be provided upon registration. Participants may also visit https://ibn.fm/biBVc to join a live and archived webcast of the call.

To view the full press release, visit https://ibn.fm/dgTyG

About iClick Interactive Asia Group Limited

Founded in 2009, iClick is a leading enterprise and marketing cloud platform in China. iClick’s mission is to empower worldwide brands to unlock the enormous market potential of smart retail. With its leading proprietary technologies, iClick’s full suite of data-driven solutions helps brands drive significant business growth and profitability throughout the full consumer lifecycle. Headquartered in Hong Kong, iClick currently operates in 11 locations across Asia and Europe. For more information, please visit ir.i-Click.com.

NOTE TO INVESTORS: The latest news and updates relating to ICLK are available in the company’s newsroom at http://ibn.fm/ICLK

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, today announced that a national health plan selected its solution to drive self-service across its mental wellbeing care resources. According to the update, Dario’s behavioral health solution will become part of the plan’s platform to increase access to navigation, self-help and coaching. “We are thrilled to collaborate with the plan to provide a more consumer-friendly, digital and seamless experience for users. Our ability to connect people quickly and conveniently to the right care for their needs with proven, evidence-based tools will make it easier for members to achieve better health,” said Rick Anderson, president of Dario. “We expect to reach close to ten million members with access to Dario’s behavioral health solution over the next couple of years. The agreement between the plan and Dario is expected to begin generating potential revenue in the third quarter of 2022 with broad-based roll out anticipated to commence in 2023.”

To view the full press release, visit https://ibn.fm/wIgof

About DarioHealth Corp.

DarioHealth is a leading digital therapeutics (“DTx”) company revolutionizing how people with chronic conditions manage their health through a user-centric multi-chronic condition platform. Dario’s platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company’s user-centric platform offers people continuous and customized care for health, disrupting the traditional episodic approach to health care. This approach empowers people to holistically adapt their lifestyles for sustainable behavior change, driving exceptional user satisfaction, retention and results. Making the right thing to do the easy thing to do. Dario provides its highly user rated solutions globally to health plans and other payors, self-insured employers, providers of care and directly to consumers. To learn more about DarioHealth and its digital health solutions, or for more information, visit www.DarioHealth.com.

NOTE TO INVESTORS: The latest news and updates relating to DRIO are available in the company’s newsroom at http://ibn.fm/DRIO  

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Nextech (CSE: NTAR) (OTCQB: NEXCF) (FSE: N29), a metaverse company and leading provider of augmented reality (“AR”) experience technologies and 3D model services, today announced that it has signed numerous new 3D modeling deals throughout the month of July and early August 2022. “Our ARitize 3D offering is being widely accepted by both enterprise customers as well as Shopify merchants and Amazon, which has led to strong foundational growth of our business in 3D models for ecommerce in the first half of 2022. A lot of the deals in the first half were to ‘test’ 3D models and see how the integration between platforms work. Now that we have laid the foundation, we are seeing strong re-orders and are expecting an acceleration of new customer contracts. Also, our existing customers are now exiting the ‘test’ phase, which usually lasts three-six months, and are now entering larger 12 month MRR contracts,” said Nextech AR CEO Evan Gappelberg. “We expect these existing customers’ re-orders and scaling up of global demand for everything 3D to drive our growth in Q3, Q4 and 2023 as the ecommerce industry demands shifts into high gear for Web 3.0 and emerging digital technologies. In anticipation of this rapidly growing demand, we are ramping up our 3D modelling capabilities from thousands of models per month to tens of thousands of 3D models per month. We are also expanding our revenue potential through the expansion of our technology stack with the most recent launch of our ARitize Configurator. More and more companies and brands within the ecommerce ecosystem are recognizing the benefits and ROI of our ARitize 3D product offering. We firmly believe that the transition from flat 2D photos to 3D models is now in full swing and that 3D models are currently being established as the standard in e-commerce throughout the globe.”

To view the full press release, visit https://ibn.fm/CWdxH

About Nextech AR Solutions Corp.

Nextech is the engine accelerating the growth of the metaverse. Using breakthrough AI, Nextech AR is able to quickly, easily and affordably ARitize (transform) vast quantities and varieties of existing assets at scale making products, people and places ready for interactive 3D use, giving creators at every level all the essential tools they need to build out their digital AR vision in the metaverse. The company’s platform-agnostic tools allow brands, educators, students, manufacturers, creators, and technologists to create immersive, interactive and the most photo-realistic 3D assets and digital environments, compose AR experiences, and publish them omnichannel. With a full suite of end-to-end AR solutions in 3D commerce, education, events, and industrial manufacturing, Nextech AR is in a unique position to meet the needs of the world’s biggest brands and all metaverse contributors. For more information about the company, visit www.NextechAR.com.

NOTE TO INVESTORS: The latest news and updates relating to NEXCF are available in the company’s newsroom at https://ibn.fm/NEXCF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF) announced that its board of directors has approved the granting of stock options exercisable for a total of 2,725,000 common shares to its directors, officers and consultants at an exercise price of CA$0.15 per common share. According to the update, all options were granted pursuant to the company’s stock option plan and are subject to the terms of the applicable grant agreements and the requirements of the TSX Venture Exchange. The options are subject to a vesting period of one year, with 1/4 of the options vesting three months after the date of the grant and the remaining vesting on a quarterly basis thereafter. Subject to the optionees continuing to act as directors, officers or consultants of the company, the options expire five years from the date of the grant.

To view the full press release, visit https://ibn.fm/trssF

About Avricore Health Inc.

Avricore Health is a pharmacy service innovator focused on acquiring and developing early stage technologies aimed at moving pharmacy forward. Through its flagship offering HealthTab(TM) (a wholly owned subsidiary), its mission is to make actionable health information more accessible to everyone by creating the world’s largest network of rapid testing devices in community pharmacies. For more information about the company, visit www.AvricoreHealth.com.

NOTE TO INVESTORS: The latest news and updates relating to AVCRF are available in the company’s newsroom at https://ibn.fm/AVCRF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Industrial Nanotech (OTC: INTK), a global nanoscience solutions and research leader, today announced that, through its wholly owned subsidiary, Syneffex Inc., it has entered into a distribution agreement with Lowe’s Companies Inc. (NYSE: LOW). According to the update, Syneffex products will be available on Lowe’s website for shipping and in-store pickup in approximately two weeks. “It’s great to have a powerhouse such as Lowe’s be a distribution point for Syneffex products,” said Eric Graham, VP of sales for Syneffex. “We look forward to this venture and the opportunity it affords Industrial Nanotech Inc.”

To view the full press release, visit https://ibn.fm/EV9lO

About Industrial Nanotech Inc.

Industrial Nanotech is a global nanoscience solution and product development leader. For more information, visit the company’s website at www.Industrial-Nanotech.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

LeddarTech(R), a global leader in providing the most flexible, robust and accurate ADAS and AD sensing technology, today announced a series of events in the United States and China focused on demonstrating its newest technology, LeddarVision(TM). LeddarTech utilizes raw data fusion to detect very small obstacles on the road with better detection rates and fewer false alarms than legacy “object fusion” solutions. Unclassified obstacles are also detected, providing an additional layer of safety to the vehicle. LeddarVision is a flexible, robust, cost-effective, sensor-agnostic and scalable auto-grade solution that delivers highly accurate 3D environmental models. The software additionally supports all SAE autonomy levels by applying AI and computer vision algorithms to fuse raw data from sensors employed in L2-L5 applications. As detailed in the announcement, LeddarTech intends to showcase LeddarVision at the following events: 12th New Energy Vehicle International Forum 2022 – Aug. 18-19 – Suzhou, China, as well as the ADAS & Autonomous Vehicle Technology Expo and Conference – Sept. 7-8 – San Jose, California.

To view the full press release, visit https://ibn.fm/hcTIZ

About LeddarTech

Founded in 2007, LeddarTech is a comprehensive end-to-end environmental sensing company that enables customers to solve critical sensing, fusion and perception challenges across the entire value chain. LeddarTech provides cost-effective perception solutions scalable from level 2 ADAS to level 5 full autonomy with LeddarVision(TM), a raw-data sensor fusion and perception platform that generates a comprehensive 3D environmental model from a variety of sensor types and configurations. LeddarTech also supports LiDAR manufacturers and tier 1-2 automotive suppliers with key technology building blocks such as LeddarSteer(TM) digital beam steering and the LeddarEngine(TM), which is built on LeddarTech’s Leddar(TM) technology employing patented signal acquisition and processing techniques to generate a richer and cleaner return signal at a lower cost. The LeddarEngine comprises a highly integrated, scalable LiDAR SoC and software combination that enables LiDAR developers and tier 1-2 automotive suppliers to design their own LiDAR solutions. The company is responsible for several innovations in cutting-edge automotive and mobility remote-sensing applications, with over 120 patented technologies (granted or pending) enhancing ADAS and autonomous driving capabilities. For more information about the company, visit www.LeddarTech.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

D-Wave (NYSE: QBTS), a leader in quantum computing systems, software and services and the only company building both quantum annealing and gate-based quantum computers, has announced that it will release its financial results for the second quarter ended June 30, 2022. The results will be announced after market close on Tuesday, Aug. 16, 2022, via press release, to be available on the D-Wave Investor Relations website.

In conjunction with the announcement, D-Wave will host a conference call at 4:30 p.m. ET on Aug. 16, where its Chief Executive Officer Alan Baratz and Chief Financial Officer John Markovich will discuss the company’s financial results and business outlook. Interested parties may join the call by dialing 1-877-407-3982 (domestic) or 1-201-493-6780 (international) and entering conference ID: 13732159. A live webcast and subsequent replay will be available on the D-Wave Investor Relations website at https://ir.dwavesys.com/events-and-presentations.

To view the full press release, visit https://ibn.fm/M0upc

About D-Wave Quantum Inc.

D-Wave is a leader in the development and delivery of quantum computing systems, software and services, and is the world’s first commercial supplier of quantum computers — and the only company building both annealing quantum computers and gate-model quantum computers. The company’s mission is to unlock the power of quantum computing today to benefit business and society. D-Wave does this by delivering customer value with practical quantum applications for problems as diverse as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, cybersecurity, fault detection and financial modeling. D-Wave systems are being used by some of the world’s most advanced organizations, including NEC Corporation, Volkswagen, DENSO, Lockheed Martin, Forschungszentrum Jülich, University of Southern California, and Los Alamos National Laboratory. D-Wave’s headquarters are based in Palo Alto, California, with Canadian operations and the Quantum Engineering Center of Excellence based near Vancouver, Canada. For more information about the company, please visit www.DWaveSys.com.

NOTE TO INVESTORS: The latest news and updates relating to QBTS are available in the company’s newsroom at https://ibn.fm/QBTS

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Pono Capital Two (NASDAQ: PTWOU) has announced the closing of its initial public offering of 10,000,000 units, each at a price of $10.00, including 1,500,000 units issued pursuant to the full exercise by the underwriters of their over-allotment option. The units are listed on the Nasdaq Global Market and began trading under the ticker symbol PTWOU on Aug. 5, 2022. Each unit consists of one share of Class A common stock and one redeemable warrant. Each warrant entitles the holder to purchase one share of Class A common stock at a price of $11.50 per share. Once the securities comprising the units begin separate trading, the shares of Class A common stock and warrants are expected to be listed on the Nasdaq under the symbols PTWO and PTWOW, respectively. EF Hutton, division of Benchmark Investments LLC, acted as the sole book running manager for the offering. Nelson Mullins Riley & Scarborough LLP served as legal counsel to the company, while Kirkland & Ellis LLP served as counsel to EF Hutton.

To view the full press release, visit https://ibn.fm/quzw4

About Pono Capital Two Inc.

Pono Capital Two is a newly incorporated blank check company whose business purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses or entities. It intends to focus its search for a target business addressing a large market opportunity with a company that is driving its growth through technology. Potential industries that fit this focus are enterprise security and operations applications, cloud-based content and digital streaming services, drone technology and service, artificial intelligence (“AI”), consumer health care and wellness, biomedical technology, entertainment/gaming, distance learning, and e-sports companies. Pono Capital Two is led by CEO Darryl Nakamoto, CFO Allison Van Orman and Chairman of the Board Dustin Shindo.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Ontrak (NASDAQ: OTRK), a leading artificial intelligence and telehealth-enabled healthcare company, has closed its previously announced registered direct offering for $4 million. The offering was with institutional investors and involved the purchase and sale of shares of the company’s common stock at $0.80 per share. According to the announcement, the per-share purchase price was at-the-market in accordance with Nasdaq rules. Roth Capital Partners acted as sole placement agent for the offering

To view the full press release, visit https://ibn.fm/ookrV

About Ontrak Inc.

Ontrak is a leading artificial intelligence and telehealth-enabled healthcare company whose mission is to help improve the health and save the lives of as many people as possible. Ontrak identifies, engages, activates and provides care pathways to treatment for the most vulnerable members of the behavioral health population who would otherwise fall through the cracks of the healthcare system. The company engages individuals with anxiety, depression, substance-use disorder and chronic disease through personalized care coaching and customized care pathways that help them receive the treatment and advocacy they need, despite the socio-economic, medical and health system barriers that exacerbate the severity of their comorbid illnesses. The company’s integrated intervention platform uses artificial intelligence, predictive analytics and digital interfaces combined with dozens of care-coach engagements to deliver improved member health, better healthcare system utilization, and durable outcomes and savings to healthcare payors. For more information about the company, please visit www.OntrackHealth.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Playgon Games (TSX.V: DEAL) (OTCQB: PLGNF) (FSE: 7CR), a propriety SaaS technology company delivering mobile live-dealer technology to online gaming operators globally, is updating information regarding its recent milestone release. The company is reporting that during the first week of August, daily wagering turnover (handle) increased by 30% as compared to the average daily wagering last month. That upward trend is expected to continue with recent core integrations coming online and additional key account integrations being finalized; the company also anticipates accelerated growth in turnover and player activity, all of which will contribute to continued revenue growth. “With a number of new operators coming online in the next 30 days, we anticipate record increases in our key performance indicators to become the norm,” said Playgon Games CEO Darcy Krogh in the press release. “As a young company with a new product in the marketplace, we look to these data points as validation of our product and of our business plan. We’re on the right path.”

To view the full press release, visit https://ibn.fm/IOdBp

About Playgon Games Inc.

Playgon is a SaaS technology company focused on developing and licensing digital content for the growing iGaming market. The company provides a multitenant gateway that allows online operators the ability to offer their customers innovative iGaming software solutions. Its current software platform includes Live Dealer Casino, E-Table games and Daily Fantasy Sports, which, through a seamless integration at the operator level, allows customer access without having to share or compromise any sensitive customer data. As a true business-to-business digital content provider, Playgon products are ideal turnkey solutions for online casinos, sportsbook operators, land-based operators, media groups and big database companies. For more information about the company, please visit www.Playgon.com. 

NOTE TO INVESTORS: The latest news and updates relating to PLGNF are available in the company’s newsroom at https://ibn.fm/PLGNF  

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

One of the top summits in the investor space, the Q3 Investor Summit will be held on August 16-17, 2022, as a virtual event. The Q3 Investor Summit offers phenomenal opportunities for mid-cap and small-cap companies to connect with potential investors.

Investors looking for novel investment opportunities can discover innovative ideas and a new arena of investment scope at the conference. Dynamic mid and small-cap companies will be at the Q3 event to present themselves, and many seasoned and well-qualified investors who have an intention to buy in…

Read More>>

To learn more, please visit https://investorsummitgroup.com/.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

PlantX Life (CSE: VEGA) (OTCQB: PLTXF) (Frankfurt: WNT1), the digital face of the plant-based community, operating a one-stop shop for plant-based products, today announced that its company, Portfolio Coffee, has established a new partnership. The collaboration is with the Canadian Barista & Coffee Academy, a dedicated, inclusive school offering beginner, advanced and specialized espresso training and business courses, under which the academy will utilize Portfolio Coffee to train Level 1, 2 and 3 baristas. “This innovative partnership helps new and aspiring baristas to become familiar with the exceptional taste and aroma of our Portfolio Coffee brand, while providing students a range of functional and complex varieties to help learn about different coffees,” PlantX CEO Lorne Rapkin said in the news release.

To view the full press release, visit https://ibn.fm/B4INF

About PlantX Life Inc.

As the digital face of the plant-based community, PlantX’s platform is a one-stop shop for plant-based products. With its fast-growing category verticals, the company offers customers across North America more than 5,000 plant-based products. In addition to offering delivery service for meals and indoor plants, the company currently has plans underway to expand its product lines to include a juice and coffee company. The company uses its digital platform to build a community of likeminded consumers and, most importantly, to provide education. Its successful enterprise is being built and fortified on partnerships with the top nutritionists, chefs and brands. The company’s digital presence works to eliminate the barriers to entry for anyone interested in living a plant-based lifestyle and thriving in a longer, healthier and happier life. For more information, visit the company’s investor website at https://Investor.PlantX.com.

NOTE TO INVESTORS: The latest news and updates relating to PLTXF are available in the company’s newsroom at https://ibn.fm/PLTXF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Golden Triangle Ventures (OTC: GTVH) has announced that Sonder Fulfilment has successfully entered the Brazilian CBD market, which is a significant milestone for the company. Sonder Fulfillment is a wholly owned subsidiary of Golden Triangle Ventures, providing an array of synergies to the many companies and projects within GTV. Sonder Fulfillment achieved that milestone when it executed an initial order for Volcanic Green, a new client that is expanding its CBD line into the growing CBD market in Brazil. According to the announcement, Volcanic Green’s product line will initially include two tincture formulas specifically formulated for day (focus, energy alertness) and night (calming, soothing, and assistance with rest and sleep) applications; the line will also offer general wellness gummies. Sonder Fulfillment shipped the products to Volcanic Green’s fulfillment center in Miami on July 29, 2022, and the products are being prepared for shipment to Brazil. “We have worked hand-in-hand with Volcanic Green for several months to navigate the regulatory environment and get their initial line of CBD products approved in Brazil,” said Sonder Fulfillment vice president Joshua Weaver in the press release. “Not only did we formulate their initial line of products, but we also designed their brand and have provided critical assistance for logistics and other items related to legally exporting their product into Brazil. I believe this partnership will be a longstanding one, and I look forward to the bright future ahead in one of the newest CBD markets in the world. . . . Looking to the future, Sonder Fulfillment see’s expansion from Brazil into other Latin American countries. Additionally, Volcanic Green is also working closely with Sonder Fulfillment to expand distribution networks for Le Pragma within Europe. Through these opportunities, Sonder Fulfillment seeks to accomplish their goal of becoming a world leader in the production and distribution of cannabinoid-driven wellness. Utilizing these new developments as a springboard, the company anticipates a strong expansion as its journey unfolds.”

To view the full press release, visit https://ibn.fm/XYPzO

About Golden Triangle Ventures Inc.

Golden Triangle Ventures is a multifaceted consulting company pursuing ventures in the health, entertainment, technology, fulfillment, and food & beverage industries, with many additional projects being developed that provide synergistic values to these divisions. The company aims to purchase, acquire and/or joint venture with established entities that management can assist and help develop into unique opportunities. Additionally, GTVH provides a professional corporate representation service to different companies in these sectors while consulting on a variety of business development objectives. The goods and services represented are driven by innovators who have passion for and commitment to these marketplaces. The company plans to utilize relationships and create a platform for new and existing businesses to strengthen their products and/or services. For more information about the company, visit www.GoldenTriangleInc.com.

NOTE TO INVESTORS: The latest news and updates relating to GTVH are available in the company’s newsroom at https://ibn.fm/GTVH

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.